NCT00036790 2019-12-17Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerUniversity of Wisconsin, MadisonPhase 1 Completed
NCT00096837 2006-06-08A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple MyelomaPharmacyclics LLC.Phase 2 Completed25 enrolled